AXL and neoplasm: Its exceptional role in GBM was presented in previous studies showing that experimental inhibition of the RTK-AXL pathway with dominant negative-mutant glioma cells of AXL receptor (SF126 AXL-DN) suppresses glioma growth and prolongs survival in orthotopic tumor model in mice [15].